Dyne Therapeutics Inc (DYN)
25.65
-0.62
(-2.38%)
USD |
NASDAQ |
May 07, 16:00
25.65
0.00 (0.00%)
After-Hours: 20:00
Dyne Therapeutics Total Liabilities (Quarterly): 44.22M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 44.22M |
December 31, 2023 | 73.79M |
September 30, 2023 | 53.21M |
June 30, 2023 | 44.54M |
March 31, 2023 | 46.71M |
December 31, 2022 | 53.96M |
September 30, 2022 | 49.94M |
June 30, 2022 | 52.97M |
March 31, 2022 | 51.30M |
Date | Value |
---|---|
December 31, 2021 | 57.47M |
September 30, 2021 | 52.76M |
June 30, 2021 | 14.55M |
March 31, 2021 | 13.45M |
December 31, 2020 | 10.97M |
September 30, 2020 | 14.63M |
June 30, 2020 | 14.29M |
December 31, 2019 | 2.40M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.40M
Minimum
Dec 2019
73.79M
Maximum
Dec 2023
38.30M
Average
46.71M
Median
Mar 2023
Total Liabilities (Quarterly) Benchmarks
Solid Biosciences Inc | 38.46M |
Sana Biotechnology Inc | 277.79M |
Tenaya Therapeutics Inc | 31.09M |
Prime Medicine Inc | 60.78M |
CEL-SCI Corp | 16.06M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 522.28M |
Shareholders Equity (Quarterly) | 478.06M |